Diagnostics
Diagnostics, Medical Device, News, Syndication, Xconomy »
San Diego Life Sciences Roundup: Allergan, Qualcomm Life, & More |  |
|
Posted by sandiegobiotech November 21st, 2012 .
| |
| No Comments |
We saw a spate of funding deals and other activity in the week or so preceding Thanksgiving. Here’s our roundup of life sciences news, with best wishes from Xconomy for your Thanksgiving holiday….
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Dear Members of Congress: Don’t Gut the NIH Budget | |
|
Posted by sandiegobiotech October 19th, 2012 .
| |
| No Comments |
In 1973, research spearheaded by Herbert Boyer at the University of California San Francisco and Stanley Cohen at Stanford University led to the discovery of recombinant DNA technology and, in turn,…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Diagnostics Instrument Maker AutoGenomics Files Again for IPO | |
|
Posted by sandiegobiotech October 1st, 2012 .
| |
| No Comments |
AutoGenomics, a Vista, CA-based company that specializes in molecular diagnostics systems, has filed for a $65 million Initial Public Offering (IPO), according to a recent regulatory filing. The…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names | |
|
Posted by sandiegobiotech August 13th, 2012 .
| |
| No Comments |
The average American on the street has a Facebook account, an opinion about Facebook, heard about the Facebook initial public offering, and knows it collapsed. That same person doesn’t see how their…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Bridesmaid No More: It is Time For Diagnostics To Shine | |
|
Posted by sandiegobiotech July 2nd, 2012 .
| |
| No Comments |
A 41 year old HIV patient sits down with his physician to discuss his options. After a year of diagnostic tests that indicate stable CD4 cell counts, viral load, and creatinine levels, there has been…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Who’s Still Active Among the Early-Stage Biotech VCs? | |
|
Posted by sandiegobiotech July 2nd, 2012 .
| |
| No Comments |
Imagine for a moment you’re a hotshot biomedical scientist at a university. You have invented a technology in your lab that you think has potential to make a big difference for the world of medicine….
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Three Good Things About BIO 2012, and Four Not-so-Good | |
|
Posted by sandiegobiotech June 18th, 2012 .
| |
| No Comments |
People from all over the world are gathering in Boston today to talk about biotech dreams. Like most years at the Biotechnology Industry Organization’s international convention, at least 15,000…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines | |
|
Posted by sandiegobiotech June 5th, 2012 .
| |
| No Comments |
There’s so much going on in the world of cancer drug R&D that it’s hard to keep up with all the news about drugs that are changing the standards of care. And quite a few of those standards are…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push | |
|
Posted by sandiegobiotech April 30th, 2012 .
| |
| No Comments |
Hologic has made big-money acquisitions before, and today it’s making another sizable one. The Bedford, MA-based maker of women’s health products (NASDAQ: HOLX) said today it has agreed to purchase…
[[Click headline to continue reading.]]
More...Diagnostics, News, Syndication, Xconomy »
Illumina Stays Independent, Roche Walking Away | |
|
Posted by sandiegobiotech April 18th, 2012 .
| |
| No Comments |
Illumina will remain an independent company, at least for now. The San Diego-based company (NASDAQ: ILMN), the market leading maker of DNA sequencing instruments, fended off a hostile takeover bid by…
[[Click headline to continue reading.]]
More...
